Rosa Johnson Scleroderma, an autoimmune disease, causes an abnormal toughening of the area of the body affected, which can be anywhere from the skin to internal organs, which leads to a steady loss of function. The Scleroderma Foundation estimates that about 300,000 Americans have scleroderma, and the disease is…
The chief executive officer of clinical stage biopharmaceutical company Corbus Pharmaceuticals Holdings, Yuval Cohen, Ph.D., is presenting an update on the company’s research, as well as revision of previous clinical developments regarding Corbus’s lead product candidate, Resunab, at the Leerink Partners Rare Disease Roundtable. The product candidate is being studied by the drug…
The Scleroderma Foundation announced that their national Board of Directors is merging the Southern California Chapter with the Greater San Diego Chapter, in order to increase the efficiency of their support and education programs. The merger was proposed by the chapters themselves and approved by the board, and the…
Protagen AG, which specializes in diagnostic medical devices for autoimmune diseases, has launched its first ELISA research use test kit, developed for Systemic Sclerosis (SSc), the ADx®SSc Multilisa®. The diagnostic test was developed by Protagen with the purpose of combining both the identification of novel disease markers and two standard…
Get regular updates to your inbox.